1. 01 DOSE ESCALATION WITH ORIGINATOR INFLIXIMAB IS MORE COMMON THAN STANDARD DOSING IN PEDIATRIC IBD – THE DEVELOP EXPERIENCE. (7th February 2019) Authors: Griffiths, Anne; Escher, Johanna; Izanec, James; Busse, Christopher; Wang, Yanli; Dubinsky, Marla Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 02 NEW ONSET AUTOIMMUNE DISORDERS, PRIMARILY PSORIASIS, IN ANTI-TNF BIOLOGIC EXPOSED PEDIATRIC PATIENTS – THE DEVELOP EXPERIENCE. (7th February 2019) Authors: Colletti, Richard; Griffiths, Anne; Veereman, Gigi; Escher, Johanna; Izanec, James; Busse, Christopher; Wang, Yanli; Gold, Benjamin Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022) Authors: Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 1(2022) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P037 Patterns of Care Among Patients Treated With Ustekinumab for Crohn's Disease: Results From a Chart Review. (December 2019) Authors: Ruetsch, Charles; Davis, Tigwa; Clerie, Jennifer; Obando, Camilo; Izanec, James; Muser, Erik Journal: American journal of gastroenterology Issue: Volume 114:2019 Supplement (2019)Abstracts 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P060 COMBINATION THERAPY WITH TNF-INHIBITORS AND IMMUNOMODULATORS ARE ASSOCIATED WITH SHORTER DURATION TO FIRST SERIOUS INFECTION – THE DEVELOP EXPERIENCE. (7th February 2019) Authors: Gold, Benjamin; Cucchiara, Salvatore; Izanec, James; Busse, Christopher; Wang, Yanli; Escher, Johanna Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P062 DOSE ESCALATION WITH ORIGINATOR INFLIXIMAB OR COMBINATION THERAPY WITH ORIGINATOR INFLIXIMAB AND IMMUNOMODULATORS SIGNIFICANTLY INCREASES RISK FOR SERIOUS ADVERSE EVENTS IN PEDIATRIC IBD – THE DEVELOP EXPERIENCE. (7th February 2019) Authors: Veereman, Gigi; Busse, Christopher; Wang, Yanli; Izanec, James Journal: Inflammatory bowel diseases Issue: Volume 25(2019)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P28 Effect of endoscopic disease criteria on endoscopic outcomes in the SEAVUE study. (19th June 2022) Authors: Allez, Matthieu; Lewis, James; Hanauer, Stephen; Danese, Silvio; Irving, Peter; Gasink, Chrispher; Hoops, Tim; Izanec, James; Ma, Tony; Loftus, Edward; Scherl, Ellen; Pannacione, Remo; Sandborn, William; Sands, Bruce Journal: Gut Issue: Volume 71(2022)Supplement 1 Page Start: A50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Relationship Between Crohn's Disease Activity Index and Patient‐Reported Outcomes for Crohn's Disease Patients in the United States: 763. (October 2019) Authors: Obando, Camilo; Ding, Zhijie; Izanec, James; Sikirica, Mirko; Lucas, James; Kemp, Jessalyn; Muser, Erik Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Relationship Between Partial Mayo Score and Patient‐Reported Outcomes for Ulcerative Colitis Patients in the United States: 710. (October 2019) Authors: Ding, Zhijie; Obando, Camilo; Izanec, James; Sikirica, Mirko; Lucas, James; Kemp, Jessalyn; Muser, Erik Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S801 Long-Term Persistence to Ustekinumab and Adalimumab Among Bio-Naïve Patients With Crohn's Disease. (October 2022) Authors: Zhdanava, Maryia; Ding, Zhijie; Manceur, Ameur M.; Holiday, Christopher; Zhao, Ruizhi; Izanec, James; Pilon, Dominic Other Names: Kachroo Sumesh presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗